Publisher
Springer Science and Business Media LLC
Reference23 articles.
1. Hemmer B, et al. Diagnose und Therapie der Multiplen Sklerose, Neuromyelitis-optica-Spektrum-Erkrankungen und MOG-IgG-assoziierten Erkrankungen, S2k-Leitlinie, 2021. Leitlinien für Diagnostik und Therapie in der Neurologie. 2021; www.dgn.org/leitlinien. Zuletzt abgerufen am 20.06.2021. Retrieved June 20, 2021.
2. Sorensen, P. S., Sellebjerg, F., Hartung, H. P., Montalban, X., Comi, G., & Tintore, M. (2020). The apparently milder course of multiple sclerosis: Changes in the diagnostic criteria, therapy and natural history. Brain, 143(9), 2637–2652. https://doi.org/10.1093/brain/awaa145.
3. Montalban, X., Gold, R., Thompson, A. J., et al. (2018). ECTRIMS/EAN Guideline on the pharmacological treatment of people with multiple sclerosis. Multiple Sclerosis Journal, 24(2), 96–120 [Erratum in: Mult Scler, 2020. 26(4):517] und Eur J Neurol, 2018. 25(2):215–37 [Erratum in: Eur J Neurol, 2018. 25(3):605].
4. Reynders, T., D'Haeseleer, M., De Keyser, J., Nagels, G., & D'Hooghe, M. B. (2017). Definition, prevalence and predictive factors of benign multiple sclerosis. eNeurologicalSci, 7, 37–43. https://doi.org/10.1016/j.ensci.2017.05.002.
5. Chung, K. K., Altmann, D., Barkhof, F., Miszkiel, K., Brex, P. A., O'Riordan, J., … Chard, D. T. (2020). A 30-year clinical and magnetic resonance imaging observational study of multiple sclerosis and clinically isolated syndromes. Annals of Neurology, 87(1), 63–74. https://doi.org/10.1002/ana.25637.
Cited by
9 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献